424 related articles for article (PubMed ID: 12574225)
41. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
Trouillas J; Chevallier P; Remy C; Rajas F; Cohen R; Calle A; Hooghe-Peters EL; Rousset B
Endocrinology; 1999 Jan; 140(1):13-21. PubMed ID: 9886801
[TBL] [Abstract][Full Text] [Related]
42. Leukemia inhibitory factor (LIF) and LIF receptor in human lung. Distribution and regulation of LIF release.
Knight DA; Lydell CP; Zhou D; Weir TD; Robert Schellenberg R; Bai TR
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):834-41. PubMed ID: 10101017
[TBL] [Abstract][Full Text] [Related]
43. Insulin regulates prolactin secretion and messenger ribonucleic acid levels in pituitary cells.
Prager D; Yamashita S; Melmed S
Endocrinology; 1988 Jun; 122(6):2946-52. PubMed ID: 3286229
[TBL] [Abstract][Full Text] [Related]
44. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry.
Wang J; Ciofi P; Crowley WR
Endocrinology; 1996 Feb; 137(2):587-94. PubMed ID: 8593806
[TBL] [Abstract][Full Text] [Related]
45. Angiotensin II receptors and prolactin release in pituitary lactotrophs.
Aguilera G; Hyde CL; Catt KJ
Endocrinology; 1982 Oct; 111(4):1045-50. PubMed ID: 6288343
[TBL] [Abstract][Full Text] [Related]
46. The role of MAPK11/12/13/14 (p38 MAPK) protein in dopamine agonist-resistant prolactinomas.
Wang S; Wang A; Zhang Y; Zhu K; Wang X; Chen Y; Wu J
BMC Endocr Disord; 2021 Nov; 21(1):235. PubMed ID: 34814904
[TBL] [Abstract][Full Text] [Related]
47. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
[TBL] [Abstract][Full Text] [Related]
48. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay.
Larson GH; Koos RD; Sortino MA; Wise PM
Endocrinology; 1990 Feb; 126(2):927-32. PubMed ID: 2105207
[TBL] [Abstract][Full Text] [Related]
49. Regulation of galanin gene expression in the rat anterior pituitary gland by the somatostatin analog SMS 201-995.
Hyde JF; Howard G
Endocrinology; 1992 Nov; 131(5):2097-102. PubMed ID: 1385097
[TBL] [Abstract][Full Text] [Related]
50. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma.
Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K
Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012
[TBL] [Abstract][Full Text] [Related]
51. Leukemia inhibitory factor and neurotrophins support overlapping populations of rat nodose sensory neurons in culture.
Thaler CD; Suhr L; Ip N; Katz DM
Dev Biol; 1994 Feb; 161(2):338-44. PubMed ID: 8313987
[TBL] [Abstract][Full Text] [Related]
52. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
Chesnokova V; Melmed S
Endocrinology; 2000 Nov; 141(11):4032-40. PubMed ID: 11089533
[TBL] [Abstract][Full Text] [Related]
53. Function of galanin in the anterior pituitary of estrogen-treated Fischer 344 rats: autocrine and paracrine regulation of prolactin secretion.
Cai A; Bowers RC; Moore JP; Hyde JF
Endocrinology; 1998 May; 139(5):2452-8. PubMed ID: 9564857
[TBL] [Abstract][Full Text] [Related]
54. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
[TBL] [Abstract][Full Text] [Related]
55. Dopamine D4 receptor-mediated inhibition of cyclic adenosine 3',5'-monophosphate production does not affect prolactin regulation.
Sanyal S; Van Tol HH
Endocrinology; 1997 May; 138(5):1871-8. PubMed ID: 9112381
[TBL] [Abstract][Full Text] [Related]
56. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat.
Omori N; Evarts RP; Omori M; Hu Z; Marsden ER; Thorgeirsson SS
Lab Invest; 1996 Jul; 75(1):15-24. PubMed ID: 8683936
[TBL] [Abstract][Full Text] [Related]
57. [Homeoproteins and pituitary adenoma].
Barlier A; Pellegrini-Bouiller I; Gunz G; Jaquet P; Enjalbert A
Ann Endocrinol (Paris); 1997; 58(1):3-10. PubMed ID: 9207961
[TBL] [Abstract][Full Text] [Related]
58. Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter.
McChesney R; Sealfon SC; Tsutsumi M; Dong KW; Roberts JL; Bancroft C
Mol Cell Endocrinol; 1991 Aug; 79(1-3):R1-7. PubMed ID: 1834494
[TBL] [Abstract][Full Text] [Related]
59. Leukemia inhibitory factor as an intrapituitary mediator of ACTH secretion.
Schwartz J; Ray DW; Perez FM
Neuroendocrinology; 1999 Jan; 69(1):34-43. PubMed ID: 9892849
[TBL] [Abstract][Full Text] [Related]
60. Differences in the interaction between dopamine and estradiol on prolactin release by cultured normal and tumorous human pituitary cells.
Lamberts SW; Verleun T; Hofland L; Oosterom R
J Clin Endocrinol Metab; 1986 Dec; 63(6):1342-7. PubMed ID: 3782422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
